Zen-Bio, Inc.
Durham, NC Doing business as Zenbio Part of Bioivt, LLC
- UEI
- LQS2WJFBBUQ3
- CAGE
- 3MZW4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 325414 Biological Product (except Diagnostic) Manufacturing Primary
- 541380 Testing Laboratories and Services
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 621511 Medical Laboratories
- Corporate family
-
-
Bioivt, LLC
Parent
L2BGKGC6LJW7
- Zen-Bio, Inc. LQS2WJFBBUQ3
-
Bioivt, LLC
Parent
L2BGKGC6LJW7
- SAM.gov registration date
- Physical address
- 3920 S Alston Ave, Durham, NC 27713, USA
- Website
- zen-bio.com
- Founded
- 1995
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Human blood for research utilizing malaria parasite cultures | Defense Health Agency | $49,395 | |
| Blood | CDC Pittsburgh | $87,624 | |
| 24-012705 nhlbi, mchb requires cord blood CD34+/CD133+ cells in order to use for cell culture experiment to develop… | National Heart Lung and Blood Institute | $19,044 | |
| ZEN-BIO funding base BPA order | CDC Pittsburgh | $33,435 | |
| ZEN-BIO funding base BPA order | CDC Pittsburgh | $100,010 |
About Zen-Bio, Inc.
Zen-Bio, Inc., doing business as Zenbio, is a for-profit corporate entity located in Durham, North Carolina, specializing in the manufacture and distribution of human blood products and related biological services. Registered in SAM.gov since December 12, 2003, the company provides specialized biological materials to federal agencies, focusing on medical research, disease prevention, and public health initiatives. As a manufacturer of goods, Zenbio has established itself as a key supplier of human blood products, including cord blood cells, blood units, and specific blood-derived materials for scientific and medical research purposes.
The company has secured multiple federal contract awards from prominent agencies such as the Centers for Disease Control and Prevention (CDC), the National Heart, Lung, and Blood Institute (NHLBI), and the Defense Health Agency (DHA). These contracts involve providing diverse biological materials, including O+ packed red blood cells, A+ human male serum, cord blood CD34+/CD133+ cells, and other specialized blood units. The contracts are predominantly firm fixed-price purchase orders and Blanket Purchase Agreement (BPA) calls, ranging in value from $19,044 to $206,163. None of Zenbio's federal contract awards have been set aside for specific business categories, indicating the company competes in the open market. The contracts support critical research efforts, such as malaria vaccine research at the Walter Reed Army Institute of Research and gene therapy strategy development for the Maternal and Child Health Bureau.
Zenbio holds a single-award Blanket Purchase Agreement (BPA) with the CDC, valued at $0.00 ceiling, which was awarded on September 19, 2023, and is set to expire on September 19, 2025. This BPA allows the CDC to efficiently procure Zenbio's specialized blood products and services to support ongoing public health initiatives. Under this BPA, the agency has issued multiple call orders, including a $100,010 three-month contract ending December 19, 2023, and a $33,435 contract ending September 19, 2024. These BPA calls are specifically for "ZEN-BIO FUNDING BASE" services and are primarily focused on blood units procurement to support the CDC's disease monitoring, prevention, and research efforts in locations such as Pittsburgh, Pennsylvania, and Chamblee, Georgia.
SBA capabilities narrative
Cultured human cell systems for drug discovery. Offering adipocytes, preadipocytes, visceral adipocytes, hepatocytes, skeletal myocytes, media, reagents, RNA, Assay development services, compound screeing services and extensive contract assay services.
Quick answers
What is Zen-Bio, Inc.'s UEI?
Zen-Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is LQS2WJFBBUQ3.
What is Zen-Bio, Inc.'s CAGE code?
Zen-Bio, Inc.'s CAGE code is 3MZW4.
What is Zen-Bio, Inc.'s primary NAICS code?
Zen-Bio, Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Zen-Bio, Inc. located?
Zen-Bio, Inc.'s physical address in SAM.gov is 3920 S Alston Ave, Durham, NC 27713, USA.
Is Zen-Bio, Inc. registered in SAM.gov?
Yes. Zen-Bio, Inc.'s SAM.gov registration is active through May 27, 2027.
Who is Zen-Bio, Inc.'s parent company?
Zen-Bio, Inc. is part of Bioivt, LLC.
What is Zen-Bio, Inc.'s most recent federal award?
Zen-Bio, Inc.'s most recent federal contract award is Human blood for research utilizing malaria parasite cultures (HT942626CE004), from Defense Health Agency, on March 19, 2026.
On GovTribe
See Zen-Bio, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors